MARIA® M5:一项多中心临床研究,评估Micrima无线电波雷达乳腺成像系统(MARIA®)检测有症状乳腺病变的能力
这项多中心研究在三个试验点纳入225例有症状的乳腺病变患者(含恶性和良性病变),使用半球形无线电波天线阵列生成乳腺三维图像。MARIA®系统总体敏感度为76%,在良恶性病变及较致密乳腺中相似。图像由可获取临床信息的临床医生和不知情的盲法阅片者共同判读。
要点
- MARIA®系统利用乳腺组织介电对比差异生成三维图像,总体敏感度为76%。
- 敏感度在良性与恶性病变之间、以及较致密乳腺中表现相似。
- 图像判读分别由可获取临床信息的临床医生与盲法阅片者完成。
核心结论
- MARIA®系统在有症状乳腺病变检测中总体敏感度为76%,良恶性病变及较致密乳腺间表现相似。
研究设计与样本
- 多中心临床研究,在三个试验点纳入225例有症状的乳腺病变患者(含恶性和良性病变)。
- 使用MARIA®乳腺成像系统,以半球形无线电波天线阵列生成乳腺三维图像,利用乳腺体积内介电对比差异识别感兴趣区。
- 图像由可获取患者临床信息的临床医生和不知情的盲法阅片者共同判读。
关键影像表现/征象
- MARIA®系统利用乳腺组织介电对比差异生成三维图像以识别感兴趣区。
诊断标准与关键数值
- MARIA®系统检测有症状乳腺病变的总体敏感度为76%。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The MARIA® breast imaging system is a clinical diagnostic tool that uses a hemispherical array of radiowave antennas to generate three-dimensional images of the internal breast. The system utilises the variance of dielectric contrast within the breast volume in order to identify areas of interest for further diagnostic investigation. This multicentre study of 225 patients was conducted at three trial sites and recruited women with both malignant and benign lesions. The MARIA® images from the study were read by both clinicians who had access to the patient's clinical information, as well as by 'blind' reviewers who did not. Results from the study show an overall sensitivity of 76% for the system, which was similar across benign and malignant findings, and in denser breasts. The results from this study are outlined here and discussions on ongoing and future work with MARIA® are deliberated.
引用
- Shere M, Lyburn I, Sidebottom R, et al. MARIA® M5: A multicentre clinical study to evaluate the ability of the Micrima radio-wave radar breast imaging system (MARIA®) to detect lesions in the symptomatic breast. Eur J Radiol. 2019. PMID: 31153575. doi:10.1016/j.ejrad.2019.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。